It's truly stupid that AVXL has stalled here aroun
Post# of 1460
But today's news of two more failed amyloid-theory drugs should have told people that they need to look at alternatives, Which company has novel neurological drugs, one of which seems to .e worthy of approval for Rett Syndrome based on clinical trials so far?
We should be seeing people piling in. I hope that what we've seen is the pump and dump, and that things will stabilize until the next news item.
If, however, the stock sinks back, I will be buying a lot more.